We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-12.52%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$6.47B
AUM Growth
-$1.7B
Cap. Flow
-$612M
Cap. Flow %
-9.46%
Top 10 Hldgs %
39.4%
Holding
758
New
244
Increased
84
Reduced
79
Closed
303

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$69.4M
2
MS icon
Morgan Stanley
MS
+$50.7M
3
C icon
Citigroup
C
+$50.1M
4
AMZN icon
Amazon
AMZN
+$49.8M
5
WBD icon
Warner Bros
WBD
+$42.6M

Top Sells

Rank Stock Value
1
IFF icon
International Flavors & Fragrances
IFF
+$284M
2
TMUS icon
T-Mobile US
TMUS
+$161M
3
QCOM icon
Qualcomm
QCOM
+$151M
4
MU icon
Micron Technology
MU
+$149M
5
BABA icon
Alibaba
BABA
+$144M

Sector Composition

Rank Sector Weight
1 Healthcare 11.55%
2 Communication Services 6.92%
3 Consumer Discretionary 5.57%
4 Utilities 3.44%
5 Financials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USB icon
251
US Bancorp
USB
$100B
$1.43M 0.02%
30,973
-7,300
-19% -$364K
ORA icon
252
Ormat Technologies
ORA
$6.87B
$1.41M 0.02%
+18,000
New +$1.42M
PSTX
253
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.41M 0.02%
+545,700
New +$1.52M
AMTI
254
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1.4M 0.02%
+481,600
New +$2.02M
SQZ
255
DELISTED
SQZ Biotechnologies Company
SQZ
$1.37M 0.02%
+431,400
New +$1.55M
PCG icon
256
PG&E
PCG
$37.5B
$1.36M 0.02%
136,617
+86,216
+171% +$1.01M
TRML
257
DELISTED
Tourmaline Bio
TRML
$1.35M 0.02%
29,842
– –
INZY
258
DELISTED
Inozyme Pharma
INZY
$1.3M 0.02%
271,800
+261,800
+2,618% +$1.14M
DOYU
259
DouYu International Holdings
DOYU
$134M
$1.23M 0.02%
102,147
-234,581
-70% -$3.59M
BJ icon
260
BJs Wholesale Club
BJ
$12.3B
$1.21M 0.02%
+19,458
New +$1.22M
PRAX icon
261
Praxis Precision Medicines
PRAX
$10.2B
$1.19M 0.02%
32,445
-3,914
-11% -$418K
NMTR
262
DELISTED
9 Meters Biopharma
NMTR
$1.19M 0.02%
+227,654
New +$2.15M
EXE
263
Expand Energy Corp
EXE
$22.6B
$1.16M 0.02%
+14,342
New +$1.3M
IMPL
264
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$1.16M 0.02%
+124,800
New +$912K
LRN icon
265
Stride
LRN
$3.33B
$1.1M 0.02%
+26,867
New +$995K
PFGC icon
266
Performance Food Group
PFGC
$17.9B
$1.09M 0.02%
23,810
+16,639
+232% +$768K
ALK icon
267
Alaska Air
ALK
$5.27B
$1.09M 0.02%
27,244
+12,544
+85% +$612K
SURF
268
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.09M 0.02%
+665,400
New +$1.38M
CAR icon
269
Avis
CAR
$4.9B
$1.09M 0.02%
+7,409
New +$1.62M
BILI icon
270
Bilibili
BILI
$7.95B
$1.08M 0.02%
+42,211
New +$1.02M
CYT
271
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1.07M 0.02%
+359,500
New +$918K
TMO icon
272
Thermo Fisher Scientific
TMO
$222B
$1.07M 0.02%
1,967
-33
-2% -$18.2K
XLE icon
273
State Street Energy Select Sector SPDR ETF
XLE
$39.3B
$1.06M 0.02%
+29,800
New +$1.2M
CVS icon
274
CVS Health
CVS
$122B
$1.04M 0.02%
11,258
-3,242
-22% -$316K
KO icon
275
Coca-Cola
KO
$374B
$1.03M 0.02%
16,353
-17,484
-52% -$1.11M
9 10
11
12 13

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Laurion Capital Management held 758 positions worth $6.47B, down 21% from $8.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Laurion Capital Management withdrew a net $612M in Q2 2022, closing 303 positions and reducing 79 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $284M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Laurion Capital Management opened a new position in Morgan Stanley worth $47M.

  • Laurion Capital Management's largest Q2 2022 buy was Morgan Stanley: 618,580 shares worth $47M.
  • Laurion Capital Management added most to Lowe's Companies in Q2 2022, an estimated $69.4M increase.
  • Laurion Capital Management's biggest Q2 2022 reduction was T-Mobile US, cutting an estimated $161M.
  • Laurion Capital Management fully exited International Flavors & Fragrances in Q2 2022, selling an estimated $284M.
  • Laurion Capital Management's ten largest holdings make up 39% of its $6.47B portfolio in Q2 2022.
  • Laurion Capital Management opened 244 new positions and closed 303 in Q2 2022.
  • Laurion Capital Management's portfolio value fell 21% quarter-over-quarter to $6.47B.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.